Increased levels of endosomal CEMIP as a consequence of Wnt signaling have been implicated in mediating resistance to MEK inhibitors in BRAFV600E-mutated colorectal cancers, which is mediated by the binding of CEMIP to MEK1 and subsequent sustained ERK1/2 activation [47]. This evidence concerns the gene MAP2K1 and colorectal cancer.